banner
Doxorubicin/epalrestat co-loaded targeted liposomes
Inquiry

Cat. No.: X26-05-ZQ2887

Doxorubicin/epalrestat co-loaded targeted liposomes

Synonym: DOX/epalrestat co-loaded targeted LPs; Doxorubicin-epalrestat targeted liposomes; DOX/epalrestat co-delivery targeted liposomes

img
Product Size
100 mg; 250 mg; 500 mg; 1 g; 5 g
Price
Datasheet
MSDS
Properties
Description
This highly advanced multi-functional targeted formulation features ligand-functionalized liposomes co-loaded with doxorubicin and epalrestat. The complex structural framework encapsulates the hydrophilic anthracycline doxorubicin within its central aqueous core via an active remote-loading gradient, while simultaneously incorporating the hydrophobic rhodanine derivative epalrestat within the lipophilic tail regions of its bilayer shell, whose exterior boundary presents a dense target-mimetic affinity ligand array linked via polymer anchors. This intricate configuration coordinates intense target-mimetic ligand tracking handles with a protective dual-phase multi-cargo boundary, completely preventing drug crystallization, anthracycline leakage, and physical vesicle aggregation under ambient laboratory testing conditions.
Source
Custom synthesis
Functional Group
Doxorubicin; Epalrestat
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.